Today: 10 April 2026
Subscribe
Browse Category

NASDAQ:SSYS 21 October 2025 - 31 December 2025

Stratasys (SSYS) Q3 2025 Earnings: Revenue Slips, Cash Flow Strengthens as 3D Printing Leader Reaffirms 2025 Outlook

Stratasys (SSYS) Q3 2025 Earnings: Revenue Slips, Cash Flow Strengthens as 3D Printing Leader Reaffirms 2025 Outlook

Stratasys reported Q3 2025 revenue of $137 million, down 2.2% year over year, and a GAAP net loss of $55.6 million, more than double last year’s loss due to a $33.9 million non-cash impairment. Cash from operations improved to $6.9 million, with $255 million in cash and no debt. Shares rose about 7% intraday as investors focused on positive cash flow. Full-year guidance was reaffirmed.
13 November 2025
··
Stratasys (SSYS) Stock Surges 14%: Why 3D Printing Shares Are Heating Up

Stratasys (SSYS) Stock Surges 14%: Why 3D Printing Shares Are Heating Up

Stratasys shares jumped 13.9% to $12.44 on Oct. 20, 2025, nearing a 52-week high amid a 44% year-to-date gain. Q2 revenue was flat at $138.1 million, with management cutting full-year guidance due to delayed orders. The company acquired Forward AM and Nexa3D assets this year, expanding its polymer 3D-printing portfolio. Analyst sentiment is mixed; Needham rates SSYS a Buy, while Weiss maintains a Sell.
21 October 2025
·

Stock Market Today

  • Oricell Therapeutics Raises $110 Million Pre-IPO to Boost CAR-T Cancer Therapies
    April 9, 2026, 8:35 PM EDT. Oricell Therapeutics secured over $110 million in a pre-IPO funding round, led by Vivo Capital and other global investors, to advance its innovative CAR-T therapies targeting solid tumors. The biotech company is focusing on its lead asset, Ori-C101, a CAR-T therapy for advanced liver cancer that has shown promising clinical trial results and is preparing for pivotal trials. Oricell's proprietary technology platforms aim to strengthen its position in the competitive CAR-T therapy landscape. Chairman Huanfeng Yang emphasized the company's commitment to accelerating global development and pioneering next-generation cancer immunotherapies, including in vivo CAR-T programs, aiming to transform treatment for solid tumors, traditionally a challenging area in oncology.

Latest article

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

9 April 2026
Plug Power shares rose 2.5% to $2.715 Thursday after the company reaffirmed its target of positive EBITDAS by end-2026 and projected up to $200 million in savings from Project Quantum Leap. The update followed a major electrolyzer project win in Quebec and investor meetings in Toronto and Montreal. Plug reported 2025 revenue of $710 million and a fourth-quarter gross profit of $5.5 million.
Go toTop